Related Experiment Video
Updated: Sep 23, 2025

08:52
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
10.9K
Pertussis in Poland in 2018-2019
Agnieszka Rumik1, Iwona Paradowska-Stankiewicz1, Aneta Rosolak1
1National Institute of Public Health NIH - National Research Institute, Departament of Epidemiology of Infectious Diseases and Surveillance.
Przeglad Epidemiologiczny
|May 11, 2022
Summary
Pertussis cases decreased in Poland during 2018-2019, with young children most affected. Adults need booster pertussis (dTpa) vaccinations every 10 years due to waning immunity.
Area of Science:
- Epidemiology
- Immunology
- Public Health
Background:
- Pertussis (whooping cough) is a highly contagious vaccine-preventable disease.
- Poland has observed increasing pertussis cases since the late 1990s, particularly in adults, despite high vaccination rates.
- Immunity from pertussis vaccination wanes within 4-12 years, increasing disease risk over time.
Purpose of the Study:
- To analyze the epidemiological situation of pertussis in Poland during 2018-2019.
- To compare current pertussis incidence with previous years.
- To assess the vaccination status of children against pertussis.
Main Methods:
- Analysis of unit reports of pertussis cases registered in the National Institute of Public Health – National Institute of Hygiene (NIPH-NIH) via the SRWE system.
- Review of data from "Infectious diseases and poisonings in Poland" bulletins (2018-2019).
- Examination of data from "Vaccinations in Poland" bulletins (2018-2019).
Main Results:
- Pertussis incidence decreased to 4.0/100,000 in 2018 and 4.2/100,000 in 2019, down from 8.0/100,000 in 2017.
- The highest incidence was observed in children aged 0-4 years, followed by ages 5-9 and 10-14.
- Approximately half of all cases occurred in individuals over 15 years old; hospitalization rates were around 28-30%.
Conclusions:
- Pertussis cases declined in Poland in 2018-2019, with the highest incidence in young children.
- A concerning trend is the declining pertussis vaccination rates in 2-year-olds.
- Routine dTpa vaccination and 10-year boosters for adults are recommended to control pertussis.
More Related Videos
Related Concept Videos
Vaccinations
45.4K
Overview
45.4K
Pulmonary Tuberculosis I
337
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
337
Pneumonia I: Introduction
355
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
355
Steps in Outbreak Investigation
225
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
225
Pulmonary Tuberculosis II
424
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
424
Pulmonary Tuberculosis V
251
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
251

